Upstream Biosciences Inc. (OTC BB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced today the appointment of Dr. Artem Cherkasov to its scientific advisory board. Dr. Cherkasov is a professor in the University of British Columbia (UBC) Faculty of Medicine at Vancouver General Hospital.
